/R E P E A T -- Media Advisory - Minister Bains to attend G7 Conference on Artificial Intelligence/
MONTRÉAL, Dec. 4, 2018 /CNW/ - The Honourable Navdeep Bains, Minister of Innovation, Science and Economic Development, will participate in a discussion panel on the theme "Where does AI go from here? Envisioning a future with AI" and will deliver closing remarks at the G7 Multistakeholder Conference on Artificial Intelligence.
Media are asked to arrive no later than 11:45 a.m. for the discussion panel and no later than 3:45 p.m. for the closing remarks. Media accreditation will be done on site upon presentation of identification. Breakout and plenary sessions are closed to the media.
Follow Innovation, Science and Economic Development Canada on Twitter: @ISED_CA
SOURCE Innovation, Science and Economic Development Canada
Cyberchase, The WNET Group's multiple Emmy-winning math and environmental literacy series for kids ages 6-8, launches its 15th season with an unprecedented digital offering to meet young viewers where they are. An expansive slate of programming...
When you go on a trip, you might reach for a map to help navigate your journey or pull up GPS on your phone. But what if the destination is on another planet, and there is no map? A new project sponsored by the International Space Station (ISS)...
Nullmax, an advanced autonomous driving company, is showcasing its innovative full-set of autonomous driving solutions at the 2024 Beijing International Automotive Exhibition (Auto China 2024), held at the China International Exhibition Center. The...
Alliant Credit Union, a leader in digital banking and one of the largest credit unions in the nation, announces the appointment of four members to its board of directors. These additions to Alliant's board bring vast expertise spanning from leaders...
Information Services Group (ISG) , a leading global technology research and advisory firm, has launched a research study examining providers that help customers get the most out of the Workday cloud-based enterprise management platform.
The study...
Vertex Pharmaceuticals today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following...
